Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.



Arecor Awarded £1.05M from Innovate UK to Support the Advancement of its Diabetes Glucagon Product Towards Clinical Trials

Cambridge, UK - Arecor's Prototype liquid glucagon product shows stability and commercial viability - Partnership with Innovate UK to accelerate pre-clinical asset towards proof-of-concept & first-in-human trials.

Read the rest of entry »

Oxford Immunotec to Present at the Leerink Partners 6th Annual Global Healthcare Conference

Oxford, UK & Marlborough, USA - Oxford Immunotec Global PLC, a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced Richard Altieri, Chief Financial Officer, will present at the Leerink Partners 6th Annual Global Healthcare Conference on Thursday, February 16, 2017, at 10:00 a.m. EST at the Lotte New York Palace in New York City.

Read the rest of entry »

Summit Outline Phase 3 Programme for Novel CDI Antibiotic Ridinilazole

Oxford, UK – Summit Therapeutics plc, the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and C. difficile infection (‘CDI’), today outlines its Phase 3 programme for its novel antibiotic, ridinilazole, following recent regulatory meetings with the US Food and Drug Administration (‘FDA’) and European Medicines Agency (‘EMA’).

Read the rest of entry »

SRG appoints new Director for it's Clinical Division

Birmingham & London, UK - SRG has appointed Marianna Suckova as Director of Clinical, based in London. Marianna Suckova brings extensive knowledge of Drug Development along with a notable pedigree in sales activities, recruitment, change management and people leadership.

Read the rest of entry »

SRG puts Newcastle office expansion into motion

Birmingham & Newcastle, UK - Science, clinical and engineering recruiter SRG has expanded its Newcastle office with the addition of two new recruiters. Joining the team are Associate Consultants Richard McDermott and Luke Argent, who arrive in response to growing demand for specialist recruitment services in the North East.

Read the rest of entry »

Glide Technologies Announces Successful £3.2 Million ($4.0 Million) Fundraising

Oxford, UK – Glide Technologies, the pharmaceutical development and device company focused on the needle-free administration of solid dose formulations, today announced the successful completion of a funding round totalling £3.2 million ($4.0 million). The fundraising was supported by a number of existing investors.

Read the rest of entry »

OBN Announces Venner Shipley as New Corporate Sponsor

Abingdon, UK - OBN, the membership organisation supporting the UK’s innovative life sciences companies is pleased to announce today that Venner Shipley, a leading firm of European patent & trade mark attorneys and IP lawyers, has become OBN’s exclusive patent and trade mark attorney sponsor.

Read the rest of entry »

The Electrospinning Company Announces £650,000 Funding Round

Harwell, UK - The Electrospinning Company, announces that it has secured a £650,000 investment to establish itself as the leading provider of clinical-grade electrospun biomaterials to the medical device industry.  Funding has come from a network of UK angel investors, including Angels 5K, LBA, Minerva, Wroxall, Angels in MedCity and OION, as well as from the Rainbow Seed Fund.

Read the rest of entry »

Novo Nordisk Enters Collaboration with University of Oxford on Type 2 Diabetes and Invests £115m in New Research Centre

Oxford, UK & Bagsværd, Denmark­ ­- University of Oxford and Novo Nordisk today announced a landmark research collaboration focused on type 2 diabetes. The partnership will enable scientists from Novo Nordisk and University of Oxford to collaborate to discover innovative approaches for treating type 2 diabetes. As part of the collaboration, Novo Nordisk is also investing in a new research centre on the premises of the University of Oxford.

Read the rest of entry »

Oxford Finance Provides $10 Million Senior Debt Facility to Oxford BioTherapeutics

Alexandria & San Jose, USA and Oxford, UK – Oxford Finance LLC, an industry-leading specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced the closing of a $10 million senior secured term loan with Oxford BioTherapeutics (“OBT”), an international, clinical-stage biotechnology company focused on developing antibody-based therapies to treat cancer.

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.

OBN Noticeboard

Future Blends are looking for an OBN member company who could help them strip solvent from one of their process streams. Initially looking at a 1 tonne scale. If you can help, or know of someone who might be able to then please contact Shane O’Leary at Future Blends. soleary@futureblends.com.

This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc.  Just drop an email to us, team@obn.org.uk, and we will post.